Dr. Feng earned her Ph.D. in Pharmaceutical Chemistry from the University of Kansas, where her research focused on drug discovery for parasitic infectious diseases, DMPK, and drug delivery. She further expanded her expertise during her postdoctoral work, specializing in the physical characterization of small molecules and peptides. She has also worked in R&D at Eli Lilly and AbbVie, where she gained experience in developing and validating LC-MS/MS quantitative methods and addressing complex analytical challenges.
Dr. Feng earned her Ph.D. in Pharmaceutical Chemistry from the University of Kansas, where her research focused on drug discovery for parasitic infectious diseases, DMPK, and drug delivery. She further expanded her expertise during her postdoctoral work, specializing in the physical characterization of small molecules and peptides. She has also worked in R&D at Eli Lilly and AbbVie, where she gained experience in developing and validating LC-MS/MS quantitative methods and addressing complex analytical challenges.